Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Restructuring Costs (2021 - 2025)

Collegium Pharmaceutical (COLL) has 2 years of Restructuring Costs data on record, last reported at $10.9 million in Q3 2025.

  • For Q3 2025, Restructuring Costs changed N/A year-over-year to $10.9 million; the TTM value through Sep 2025 reached $38.6 million, changed N/A, while the annual FY2022 figure was $33.9 million, 640.83% up from the prior year.
  • Restructuring Costs reached $10.9 million in Q3 2025 per COLL's latest filing, up from $9.8 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $13.3 million in Q1 2025 and bottomed at $4.6 million in Q4 2021.